EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR-Cas Dynamics in Carbapenem-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Clinical Isolates from a Croatian Tertiary Hospital

Ivana Jurić, Marko Jelić iD, Manda Markanović, Lucija Kanižaj, Zrinka Bošnjak, Ana Budimir, Tomislav Kuliš iD, Arjana Tambić-Andrašević iD, Ivana Ivančić-Baće iD, Ivana Mareković

Pathogens · 2025

DOI: 10.3390/pathogens14060604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Ivana Jurić und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology, Infection Prevention and Control Department, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, CRISPR-Cas Systems, Carbapenems, Klebsiella Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School od Medicine, University of Zagreb and Faculty of Science, University of Zagreb, School of Medicine, University of Zagreb, Faculty of Science, University of Zagreb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

(1)

Background

CRISPR-Cas systems provide adaptive immunity against mobile genetic elements (MGEs) carrying antimicrobial resistance (AMR) genes. Carbapenem-resistant (CR) Klebsiella pneumoniae is a major public health concern, and the role of CRISPR-Cas in its resistance is understudied. This study explored CRISPR-Cas associations with multidrug resistance in clinical K. pneumoniae. (2)

Methods

400 K. pneumoniae isolates (200 CR and 200 carbapenem susceptible (CS)) were analyzed. Carbapenemase genes (blaOXA-48, blaNDM-1, blaKPC-2), cas1, rpoB, and CRISPR1-3 loci were identified by PCR, while only CRISPR loci were sequenced. Genetic relatedness was assessed via PFGE, MLST, and spacer analysis. Statistical analysis utilized chi-squared and Fisher’s exact tests. (3)

Results

CRISPR-Cas was present in 15.8% of isolates, mainly subtypes I-E and I-E* (93.3%), with CRISPR3 loci showing the greatest spacer diversity. Clonal complexes ST14/15/101 (CR) and ST35 (CS) were identified. blaOXA-48 was linked to CRISPR-Cas-negative strains, while blaNDM-1 and blaKPC-2 were more frequent in CRISPR-Cas-positive strains (p < 0.0001). Imipenem/relebactam resistance was higher in CRISPR-Cas-negative isolates. (4)

Conclusions

K. pneumoniae CRISPR-Cas systems correlate with specific carbapenemase profiles, suggesting pressure against blaOXA-48 acquisition. The coexistence of I-E and I-E* subtypes highlight synergies in targeting MGEs. CRISPR loci could be tools for subtyping organisms following MLST.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeCRISPR-Cas SystemsCarbapenemsKlebsiella InfectionsCarbapenem-Resistant EnterobacteriaceaeHumansbeta-LactamasesCroatiaTertiary Care CentersAnti-Bacterial AgentsMicrobial Sensitivity TestsBacterial ProteinsMultilocus Sequence TypingDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

CRISPR lociCRISPR-Cas systemKlebsiella pneumoniaeMLSTPFGEantimicrobial resistancecarbapenem resistancecarbapenemase genessubtypes I-E and I-E*

Substanzen

Carbapenemsbeta-LactamasesAnti-Bacterial AgentsBacterial Proteinscarbapenemase

Autor:innen und Institutionen

  • Clinical Microbiology, Infection Prevention and Control Department, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia.
  • Department of Clinical Microbiology, University Hospital for Infectious Diseases "Fran Mihaljević", Mirogojska 8, 10000 Zagreb, Croatia.
  • School of Medicine, University of Zagreb, Šalata 3, 10000 Zagreb, Croatia.
  • Department of Urology, University Hospital Centre Zagreb, Kišpatićeva 12, 10000 Zagreb, Croatia.
  • Molecular Biology Department, Faculty of Science, University of Zagreb, Horvatovac 102a, 10000 Zagreb, Croatia.

ORCID-Profile: Marko Jelić, Tomislav Kuliš, Arjana Tambić-Andrašević, Ivana Ivančić-Baće

Förderung

  • School od Medicine, University of Zagreb and Faculty of Science, University of Zagreb
  • School of Medicine, University of Zagreb
  • Faculty of Science, University of Zagreb

Zitieren

APA

Jurić, I., Jelić, M., Markanović, M., Kanižaj, L., Bošnjak, Z., Budimir, A., Kuliš, T., Tambić-Andrašević, A., Ivančić-Baće, I., & Mareković, I. (2025). CRISPR-Cas Dynamics in Carbapenem-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Clinical Isolates from a Croatian Tertiary Hospital. Pathogens. https://doi.org/10.3390/pathogens14060604

Vancouver

Jurić I, Jelić M, Markanović M, Kanižaj L, Bošnjak Z, Budimir A, et al. CRISPR-Cas Dynamics in Carbapenem-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Clinical Isolates from a Croatian Tertiary Hospital. Pathogens. 2025. doi:10.3390/pathogens14060604

BibTeX
@article{Juri2025,
  author = {Jurić, Ivana and Jelić, Marko and Markanović, Manda and Kanižaj, Lucija and Bošnjak, Zrinka and Budimir, Ana and Kuliš, Tomislav and Tambić-Andrašević, Arjana and Ivančić-Baće, Ivana and Mareković, Ivana},
  title = {CRISPR-Cas Dynamics in Carbapenem-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Clinical Isolates from a Croatian Tertiary Hospital},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14060604}
}
Kostenlos starten →